MiMedx Group, Inc. (MDXG)
6.10
-0.21
(-3.33%)
USD |
NASDAQ |
Jan 09, 16:00
6.15
+0.05
(+0.82%)
After-Hours: 20:00
MiMedx Group EPS Diluted (Quarterly): 0.1119 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -0.0704 |
| Organogenesis Holdings, Inc. | 0.111 |
| Praxis Precision Medicines, Inc. | -3.364 |
| Celularity, Inc. | -0.8758 |
| CEL-SCI Corp. | -0.7611 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 16.75M |
| Revenue (Quarterly) | 113.72M |
| Total Expenses (Quarterly) | 96.98M |
| Enterprise Value | 779.55M |
| Gross Profit Margin (Quarterly) | 83.44% |
| Profit Margin (Quarterly) | 14.73% |
| Earnings Yield | 4.48% |
| Operating Earnings Yield | 5.92% |
| Normalized Earnings Yield | 4.484 |